Glycogen Storage Disease Type IA Clinical Trial
Official title:
A Retrospective Observational Clinical Study on the Use of Continuous Glucose Monitoring for Glycemic Control in Adult and Pediatric Patients With Glycogen Storage Disease Type Ia (GSDIa)
The primary objective of this study is to assess the percentage of time patients were in normal glucose control.
Retrospective Dexcom G6 iCGM data stored in the Clarity cloud from eligible patients will be accessed and downloaded, stripped of patient-identifying information and provided to the contract research organization (CRO) to review prior to sending to the Sponsor for analysis of glycemic control. The CRO will ensure data shared with the Sponsor is de-identified and transferred over a secure file transfer platform. Further, Remote Site Specialists (RSSs) from the CRO will work with the healthcare providers (HCPs) from participating sites to obtain additional patient data including medical history, prescribed diet, cornstarch/Glycosade use and demographic data directly, if available, from the medical charts and will enter this information into an electronic data capture (EDC) system. ;
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Active, not recruiting |
NCT05139316 -
A Study of Adeno-Associated Virus Serotype 8-Mediated Gene Transfer of Glucose-6-Phosphatase in Patients With Glycogen Storage Disease Type Ia (GSDIa)
|
Phase 3 | |
| Completed |
NCT02054832 -
Sleep and Quality of Life in Patients With Glycogen Storage Disease on Standard Versus Modified Uncooked Cornstarch
|
N/A | |
| Completed |
NCT01854242 -
Study of the Relationship Between Glycogen Storage Disease Type Ia and Inflammatory Bowel Disease
|
||
| Terminated |
NCT04909346 -
Adeno-Associated Virus (AAV) Antibody Study in Subjects OTC Deficiency, GSDIa, and Wilson Disease
|
||
| Active, not recruiting |
NCT03970278 -
Study of Long-Term Safety and Efficacy on Gene Therapy in Glycogen Storage Disease Type Ia
|
||
| Completed |
NCT04311307 -
Endogenous Glucose Production in Patients With Glycogen Storage Disease Type Ia
|
Phase 1/Phase 2 |